为探讨早孕期解脲支原体(UU)、沙眼衣原体(CT)感染临床治疗中安全有效的用药方案,特将80例UU—DNA阳性和/或CT—DNA阳性的早孕患者,分阿奇霉素组、琥乙红霉素组、乳糖酸红霉素组、进行临床对照治疗观察。三组临床治愈率对比(X~2检验)差异无显著意义(P>0.05)。胃肠道副反应发生率三组对比,阿奇霉素与红霉素组对比差异有非常显著的意义(P<0.01),琥乙红霉素组与红霉素组对比有显著性差异(P<0.05)。 To investigate the safe and effective drug regimen in UU and CT infection in early pregnancy, 80 UU-DNA positive and / or CT-DNA positive pregnant women were divided into azithromycin group Erythromycin group, erythromycin lactobionate group, the clinical control treatment. There was no significant difference between the three groups in clinical cure rate (X ~ 2 test) (P> 0.05). There were significant differences in the incidence of gastrointestinal side effects among the three groups (P <0.01), but there was significant difference between erythromycin and erythromycin (P <0.05) ).